Nachrichten zur Chimerix Aktie

Chimerix, Inc. 2020 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix, Inc. (CMRX) CEO Michael Sherman on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix to Present at Credit Suisse 29th Annual Healthcare Conference

DURHAM, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of…

CHIMERIX INC: 8-K Report

8-K...…

CHIMERIX INC: 10-Q Report

10-Q...…

CHIMERIX INC: 10-Q Report

10-Q...…

More on Chimerix Q2 earnings; highlights upcoming milestones

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix, Inc. (CMRX) CEO Mike Sherman on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix, Inc. 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix (CMRX) Reports Q2 Loss, Tops Revenue Estimates

Chimerix (CMRX) delivered earnings and revenue surprises of 11.11% and 19.83%, respectively, for the quarter ended June 2020. Do the…

Recap: Chimerix Q2 Earnings

Shares of Chimerix (NASDAQ:CMRX) were flat in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 54.29%…

CHIMERIX INC: 8-K Report

8-K...…

Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020

DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of…

Chimerix names new medical chief

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer

Former Eli Lilly Veteran Brings Deep Oncology Clinical and Regulatory Expertise Former Eli Lilly Veteran Brings Deep Oncology Clinical and…

Chimerix (CMRX) Reports Q1 Loss, Lags Revenue Estimates

Chimerix (CMRX) delivered earnings and revenue surprises of -13.33% and -17.27%, respectively, for the quarter ended March 2020. Do the…

Recap: Chimerix Q1 Earnings

Shares of Chimerix (NASDAQ:CMRX) were unchanged at $2.52 after the company reported Q1 results. Quarterly Results Earnings per share rose 51.43% over…

Chimerix EPS misses by $0.02, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about buying stock in Centennial Resource Development, Chimerix, TherapeuticsMD, Pennsylvania Real Estate, or American Airlines-

NEW YORK , April 30, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

Chimerix (CMRX) Presents At Cowen and Companys 40th Annual Health Care Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

All You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy

Chimerix (CMRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a…

Chimerix, Inc. (CMRX) CEO Mike Sherman on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix, Inc. 2019 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix +13% on Q4 beat

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update

- Successful DSTAT End of Phase 2 Meeting with FDA Confirms Phase 3 Readiness; First Patient Visit Expected mid-2020 in…

Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting

Brincidofovir demonstrated a statistically significant survival advantage in two well-characterized animal models of lethal orthopoxvirus infection Brincidofovir demonstrated a statistically…

Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year-

Is (CMRX) Outperforming Other Medical Stocks This Year?...…

Chimerix down 21% despite positive DSTAT data in MDS and AML

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting

DURHAM, N.C., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating…